- Gainers: Check-Cap Ltd (NASDAQ:CHEK) +138%, Rubius Therapeutics (NASDAQ:RUBY) +81%, Intec Pharma (NASDAQ:NTEC) +33%, GenMark Diagnostics (NASDAQ:GNMK) +29%, Acer Therapeutics (NASDAQ:ACER) +18%.
- Losers: Entera Bio (NASDAQ:ENTX) -16%, NLS Pharmaceutics (NASDAQ:NLSP) -15%, Seelos Therapeutics (NASDAQ:SEEL) -14%, Eli Lilly LLY -9%, Second Sight Medical Products (NASDAQ:EYES) -5%.